EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors

Liana Nobre, Yoshiko Nakano, Ian Burns, Robert Siddaway, Michal Zápotocky, Monique Johnson, Mansuba Rana, Cyril Li, Rodney K Lyn, Richard Yuditskiy, Michelle Ku, Javal Sheth und 22 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci197391 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Liana Nobre und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology (iHOPE), Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Brain Neoplasms, Circulating Tumor DNA, Glioma, DNA, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Proof of Principle Grant- The Hospital for sick Children, na.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Liquid biopsy has emerged as a minimally invasive method for tumor diagnosis, monitoring, and therapeutic guidance. For CNS tumors, cerebrospinal fluid (CSF) provides a reliable and accessible source of tumor-derived cell-free DNA (ctDNA). METHODS This study evaluates the clinical utility of CSF liquid biopsy in a real-world prospective setting. A total of 148 CSF samples from 120 patients underwent molecular analysis using droplet digital PCR (ddPCR) and/or next-generation sequencing to detect mutations, fusions, copy number alterations, and mismatch-repair deficient signatures (MMRDness). Samples were collected via lumbar puncture ( n = 82; 45% ctDNA positive) or from ventricle sources at the time of surgery or through shunts ( n = 66; 65% ct DNA positive). RESULTS Overall, ctDNA was detected in 54% of samples with higher detection in high-grade gliomas at diagnosis (100%, 1 sample equivocal) compared with low-grade gliomas (50%). Among low-grade gliomas, ctDNA detection was higher in disseminated cases (80% versus 43%) and from ventricular versus lumbar samples (56% versus 38%). CONCLUSION Liquid biopsy distinguished relapse from second malignancy and serial sampling demonstrated the potential for ctDNA levels to track treatment response and disease progression. In patients with MMRD tumors, high MMRDness score from ctDNA supported active disease. These findings demonstrate that combined liquid biopsy assays facilitate diagnosis, monitoring, and personalized treatment decisions, offering a viable alternative to invasive surgical biopsies in pediatric CNS tumors. TRIAL REGISTRATION None. FUNDING Proof of Principle Grant from The Hospital for Sick Children; The Canadian Institutes of Health Research; The Canadian Cancer Society; The We Love You Connie Foundation; Garron Family Cancer Center at SickKids; SickKids Clinician Training Program; Ben Stelter Foundation through the Women and Children’s Health Research Institute; Jeffrey Brock Cancer Genetics Research Fellowship; Garron Family Cancer Center Research Fellowship/Scotiabank Clinician Scientist Fellowship; Atrium/CMCC and Hold’em for Life Oncology Fellowship; Tokyo Children’s Cancer Study Group Scholarship of the Gold Ribbons Network.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCirculating Tumor DNAGliomaDNA, NeoplasmHumansFemaleChildMaleAdolescentChild, PreschoolInfantBiomarkers, TumorProspective Studies

Stichwörter der Autor:innen

Brain cancerDrug therapyGeneticsMolecular diagnosisNeuroscienceOncology

Substanzen

Circulating Tumor DNADNA, NeoplasmBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Hematology/Oncology (iHOPE), Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.

Förderung

  • Proof of Principle Grant- The Hospital for sick Children
  • na

Zitieren

APA

Nobre, L., Nakano, Y., Burns, I., Siddaway, R., Zápotocky, M., Johnson, M., Rana, M., Li, C., Lyn, R. K., Yuditskiy, R., Ku, M., Sheth, J., Levine, A. B., Nesvick, C. L., Das, A., Cacciotti, C., Zelcer, S., Climans, S. A., MacDonald, M., …, & Hawkins, C. (2026). Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors. Journal of Clinical Investigation. https://doi.org/10.1172/jci197391

Vancouver

Nobre L, Nakano Y, Burns I, Siddaway R, Zápotocky M, Johnson M, et al. Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors. Journal of Clinical Investigation. 2026. doi:10.1172/jci197391

BibTeX
@article{Nobre2026,
  author = {Nobre, Liana and Nakano, Yoshiko and Burns, Ian and Siddaway, Robert and Zápotocky, Michal and Johnson, Monique and Rana, Mansuba and Li, Cyril and Lyn, Rodney K and Yuditskiy, Richard and Ku, Michelle and Sheth, Javal and Levine, Adrian B and Nesvick, Cody L and Das, Anirban and Cacciotti, Chantel and Zelcer, Shayna and Climans, Seth A and MacDonald, Maria and Negm, Logine and Chung, Jiil and Bennett, Julie and Bondoc, Andrew and Loukides, Jim and Stengs, Lucie and Edwards, Melissa and Bouffet, Eric and Ramaswamy, Vijay and Liu, Anthony Py and Huang, Annie and Bartels, Ute and Dirks, Peter B and Tabori, Uri and Hawkins, Cynthia},
  title = {Tumor-derived cell-free DNA detected in cerebrospinal fluid enables minimally invasive profiling of pediatric brain tumors},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci197391}
}
Kostenlos starten →